COLUMN-SWITCHING SOLID-PHASE TRACE-ENRICHMENT HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR MEASUREMENT OF BUPRENORPHINE AND NORBUPRENORPHINE IN HUMAN PLASMA AND URINE BY ELECTROCHEMICAL DETECTION

被引:30
作者
SCHLEYER, E [1 ]
LOHMANN, R [1 ]
ROLF, C [1 ]
GRALOW, A [1 ]
KAUFMANN, CC [1 ]
UNTERHALT, M [1 ]
HIDDEMANN, W [1 ]
机构
[1] UNIV MUNSTER,DEPT ANESTHESIOL & INTENS CARE MED,W-4400 MUNSTER,GERMANY
来源
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS | 1993年 / 614卷 / 02期
关键词
D O I
10.1016/0378-4347(93)80319-Y
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
We describe a new high-performance liquid chromatographic method using electrochemical detection for the determination of buprenorphine and norbuprenorphine in plasma and urine. The minimum concentration for detection of buprenorphine and norbuprenorphine is 40 pg/ml. The intra-assay coefficient of variation (C.V.) in plasma and urine samples ranges from 6 to 17% depending on the drug concentration. At a plasma concentration of 500 pg/ml the inter-assay C.V. is 8% for buprenorphine and 9% for norbuprenorphine. The analysis duration is 16 min. After solid-phase extraction and evaporation a valve-switching system with two Rheodyne valves enables sample enrichment, optimal sample cleaning and rapid elution of long-retained substances.
引用
收藏
页码:275 / 283
页数:9
相关论文
共 16 条
[1]   THE RADIOIMMUNOASSAY OF BUPRENORPHINE [J].
BARTLETT, AJ ;
LLOYDJONES, JG ;
RANCE, MJ ;
FLOCKHART, IR ;
DOCKRAY, GJ ;
BENNETT, MRD ;
MOORE, RA .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 18 (04) :339-345
[2]   ANALYSIS OF BUPRENORPHINE AND ITS N-DEALKYLATED METABOLITE IN PLASMA AND URINE BY SELECTED-ION MONITORING [J].
BLOM, Y ;
BONDESSON, U ;
ANGGARD, E .
JOURNAL OF CHROMATOGRAPHY, 1985, 338 (01) :89-98
[3]   CLINICAL PHARMACOKINETICS OF NARCOTIC AGONIST-ANTAGONIST DRUGS [J].
BULLINGHAM, RES ;
MCQUAY, HJ ;
MOORE, RA .
CLINICAL PHARMACOKINETICS, 1983, 8 (04) :332-343
[4]  
CONE EJ, 1984, DRUG METAB DISPOS, V12, P577
[5]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION OF BUPRENORPHINE AND ITS MAJOR METABOLITE IN URINE [J].
DEBRABANDERE, L ;
VANBOVEN, M ;
DAENENS, P .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1991, 564 (02) :557-566
[6]   PHARMACOKINETICS OF MORPHINE AND ITS SURROGATES .6. BIOANALYSIS, SOLVOLYSIS KINETICS, SOLUBILITY, PK'A VALUES, AND PROTEIN-BINDING OF BUPRENORPHINE [J].
GARRETT, ER ;
CHANDRAN, VR .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1985, 74 (05) :515-524
[7]   SENSITIVE SCREENING METHOD FOR BUPRENORPHINE IN URINE [J].
HACKETT, LP ;
DUSCI, LJ ;
ILETT, KF ;
SEOW, SSW ;
QUIGLEY, AJ .
JOURNAL OF CHROMATOGRAPHY, 1986, 374 (02) :400-404
[8]  
HEINZEL G, 1977, ARZNEIMITTEL-FORSCH, V27, P904
[9]  
HEINZEL G, 1982, PHARMACOKINETICS DRU, P207
[10]   DETERMINATION OF BUPRENORPHINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION - APPLICATION TO HUMAN AND RABBIT PHARMACOKINETIC STUDIES [J].
HO, ST ;
WANG, JJ ;
HO, WB ;
HU, OYP .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1991, 570 (02) :339-350